Psychosocial vulnerability and early life adversity as risk factors for central sensitivity syndromes

Gareth T. Jones*

*Corresponding author for this work

Research output: Contribution to journalArticle

11 Citations (Scopus)
4 Downloads (Pure)

Abstract

The aim of this narrative review of the epidemiology of central sensitivity syndromes is to provide a summary of the role of early life adversity and psychosocial/psychological factors, in the epidemiology of six main syndromes: (i) fibromyalgia/chronic widespread pain; (ii) headache/migraine; (iii) irritable bowel syndrome; (iv) temporomandibular joint disorder; (v) interstitial cystitis; and (vi) endometriosis/vulvodynia/chronic pelvic pain. The occurrence of each of the above syndromes vary between each other, and between studies. Prevalence ranges from interstitial cystitis, with a prevalence of approximately 14.5 per 100,000, to headache, with some estimates of lifetime prevalence to be around 66%. Precise risk estimates vary between studies, conditions, and exposures, although there is consistent evidence to suggest an association between early life adversity and central sensitivity syndromes (based on the six syndromes under investigation). In further support of this, a number of studies have also demonstrated dose-risk associations. There is also considerable consistency in the literature to suggest a strong association between negative psychological and psychosocial factors, and the occurrence of central sensitivity syndromes and, again, there is some evidence of a dose-risk relationship. The majority of studies in this field are cross-sectional or retrospective in design, and caution is advised when interpreting results. It is possible – indeed there is some evidence – that some findings may be subject to recall bias, and reverse causation is also a potential concern. However, there are also a number of prospective studies which provide more robust evidence.

Original languageEnglish
Article number15733971
Pages (from-to)140-153
Number of pages14
JournalCurrent Rheumatology Reviews
Volume12
Issue number2
DOIs
Publication statusPublished - 1 Aug 2016

Fingerprint

Psychology
Interstitial Cystitis
Chronic Pain
Epidemiology
Vulvodynia
Temporomandibular Joint Disorders
Pelvic Pain
Fibromyalgia
Irritable Bowel Syndrome
Endometriosis
Migraine Disorders
Causality
Headache
Prospective Studies

Keywords

  • Central sensitivity syndromes
  • Chronic pelvic pain
  • Early life adversity
  • Fibromyalgia
  • Headache/migraine
  • Irritable bowel syndrome
  • Psychological/psychosocial factors
  • Temporomandibular joint disorder

ASJC Scopus subject areas

  • Rheumatology

Cite this

Psychosocial vulnerability and early life adversity as risk factors for central sensitivity syndromes. / Jones, Gareth T.

In: Current Rheumatology Reviews, Vol. 12, No. 2, 15733971, 01.08.2016, p. 140-153.

Research output: Contribution to journalArticle

@article{b255514b1d344594a48d7419010644fe,
title = "Psychosocial vulnerability and early life adversity as risk factors for central sensitivity syndromes",
abstract = "The aim of this narrative review of the epidemiology of central sensitivity syndromes is to provide a summary of the role of early life adversity and psychosocial/psychological factors, in the epidemiology of six main syndromes: (i) fibromyalgia/chronic widespread pain; (ii) headache/migraine; (iii) irritable bowel syndrome; (iv) temporomandibular joint disorder; (v) interstitial cystitis; and (vi) endometriosis/vulvodynia/chronic pelvic pain. The occurrence of each of the above syndromes vary between each other, and between studies. Prevalence ranges from interstitial cystitis, with a prevalence of approximately 14.5 per 100,000, to headache, with some estimates of lifetime prevalence to be around 66{\%}. Precise risk estimates vary between studies, conditions, and exposures, although there is consistent evidence to suggest an association between early life adversity and central sensitivity syndromes (based on the six syndromes under investigation). In further support of this, a number of studies have also demonstrated dose-risk associations. There is also considerable consistency in the literature to suggest a strong association between negative psychological and psychosocial factors, and the occurrence of central sensitivity syndromes and, again, there is some evidence of a dose-risk relationship. The majority of studies in this field are cross-sectional or retrospective in design, and caution is advised when interpreting results. It is possible – indeed there is some evidence – that some findings may be subject to recall bias, and reverse causation is also a potential concern. However, there are also a number of prospective studies which provide more robust evidence.",
keywords = "Central sensitivity syndromes, Chronic pelvic pain, Early life adversity, Fibromyalgia, Headache/migraine, Irritable bowel syndrome, Psychological/psychosocial factors, Temporomandibular joint disorder",
author = "Jones, {Gareth T.}",
year = "2016",
month = "8",
day = "1",
doi = "10.2174/1573397112666151231113438",
language = "English",
volume = "12",
pages = "140--153",
journal = "Current Rheumatology Reviews",
issn = "1573-3971",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Psychosocial vulnerability and early life adversity as risk factors for central sensitivity syndromes

AU - Jones, Gareth T.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The aim of this narrative review of the epidemiology of central sensitivity syndromes is to provide a summary of the role of early life adversity and psychosocial/psychological factors, in the epidemiology of six main syndromes: (i) fibromyalgia/chronic widespread pain; (ii) headache/migraine; (iii) irritable bowel syndrome; (iv) temporomandibular joint disorder; (v) interstitial cystitis; and (vi) endometriosis/vulvodynia/chronic pelvic pain. The occurrence of each of the above syndromes vary between each other, and between studies. Prevalence ranges from interstitial cystitis, with a prevalence of approximately 14.5 per 100,000, to headache, with some estimates of lifetime prevalence to be around 66%. Precise risk estimates vary between studies, conditions, and exposures, although there is consistent evidence to suggest an association between early life adversity and central sensitivity syndromes (based on the six syndromes under investigation). In further support of this, a number of studies have also demonstrated dose-risk associations. There is also considerable consistency in the literature to suggest a strong association between negative psychological and psychosocial factors, and the occurrence of central sensitivity syndromes and, again, there is some evidence of a dose-risk relationship. The majority of studies in this field are cross-sectional or retrospective in design, and caution is advised when interpreting results. It is possible – indeed there is some evidence – that some findings may be subject to recall bias, and reverse causation is also a potential concern. However, there are also a number of prospective studies which provide more robust evidence.

AB - The aim of this narrative review of the epidemiology of central sensitivity syndromes is to provide a summary of the role of early life adversity and psychosocial/psychological factors, in the epidemiology of six main syndromes: (i) fibromyalgia/chronic widespread pain; (ii) headache/migraine; (iii) irritable bowel syndrome; (iv) temporomandibular joint disorder; (v) interstitial cystitis; and (vi) endometriosis/vulvodynia/chronic pelvic pain. The occurrence of each of the above syndromes vary between each other, and between studies. Prevalence ranges from interstitial cystitis, with a prevalence of approximately 14.5 per 100,000, to headache, with some estimates of lifetime prevalence to be around 66%. Precise risk estimates vary between studies, conditions, and exposures, although there is consistent evidence to suggest an association between early life adversity and central sensitivity syndromes (based on the six syndromes under investigation). In further support of this, a number of studies have also demonstrated dose-risk associations. There is also considerable consistency in the literature to suggest a strong association between negative psychological and psychosocial factors, and the occurrence of central sensitivity syndromes and, again, there is some evidence of a dose-risk relationship. The majority of studies in this field are cross-sectional or retrospective in design, and caution is advised when interpreting results. It is possible – indeed there is some evidence – that some findings may be subject to recall bias, and reverse causation is also a potential concern. However, there are also a number of prospective studies which provide more robust evidence.

KW - Central sensitivity syndromes

KW - Chronic pelvic pain

KW - Early life adversity

KW - Fibromyalgia

KW - Headache/migraine

KW - Irritable bowel syndrome

KW - Psychological/psychosocial factors

KW - Temporomandibular joint disorder

UR - http://www.scopus.com/inward/record.url?scp=84975828044&partnerID=8YFLogxK

U2 - 10.2174/1573397112666151231113438

DO - 10.2174/1573397112666151231113438

M3 - Article

AN - SCOPUS:84975828044

VL - 12

SP - 140

EP - 153

JO - Current Rheumatology Reviews

JF - Current Rheumatology Reviews

SN - 1573-3971

IS - 2

M1 - 15733971

ER -